| scholarly article | Q13442814 |
| P50 | author | Glenn T Furuta | Q64517165 |
| P2093 | author name string | Peter Ngo | |
| Donald A Antonioli | |||
| Victor L Fox | |||
| P2860 | cites work | Eosinophilic gastrointestinal disorders (EGID). | Q35624881 |
| Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice | Q44588814 | ||
| Esophagitis: a frequent consequence of gastroesophageal reflux in infancy. | Q53883671 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 1666-1670 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia | |
| P478 | volume | 101 |
| Q34030937 | 52-Year-Old Woman With Dysphagia |
| Q36100530 | A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study |
| Q39281816 | A Japanese case series of 12 patients with esophageal eosinophilia. |
| Q47651514 | A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease Symptoms |
| Q46402782 | A case of herpes esophagitis after fluticasone propionate for eosinophilic esophagitis |
| Q36113811 | A single biopsy is valid for genetic diagnosis of eosinophilic esophagitis regardless of tissue preservation or location in the esophagus |
| Q38097271 | ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). |
| Q33599939 | Administrative coding is specific, but not sensitive, for identifying eosinophilic esophagitis |
| Q38061188 | Adult versus pediatric eosinophilic esophagitis: important differences and similarities for the clinician to understand |
| Q34619973 | Advances in clinical management of eosinophilic esophagitis |
| Q37779054 | Advances in diagnostic testing for gastroesophageal reflux disease |
| Q41596292 | Age-based differences in the diagnosis and management of esophageal eosinophilia. |
| Q37739851 | Approach to dysphagia in the young patient in the era of eosinophilic esophagitis |
| Q42788067 | Are major basic protein, eotaxin-3 and leukotriene enzyme staining useful for diagnosing eosinophilic esophagitis? (Am j gastroenterol 2012;107:1503-1511). |
| Q53067886 | Are pathologists accurately diagnosing eosinophilic esophagitis in children? A 9-year single academic institutional experience with interobserver observations. |
| Q36072597 | Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study |
| Q37463526 | Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease |
| Q37146899 | Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases |
| Q36412868 | Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients |
| Q45966172 | Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. |
| Q42284196 | Contribution of endoscopy in the management of eosinophilic esophagitis |
| Q53043334 | Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. |
| Q33916143 | Curious elements of esophageal foreign body impaction and eosinophilic esophagitis. |
| Q42135109 | De-novo onset of eosinophilic esophagitis after large volume allergen exposures |
| Q38021254 | Diagnosis and management of eosinophilic esophagitis |
| Q42530515 | Diagnosis and treatment of eosinophilic esophagitis |
| Q39155749 | Diagnosis and treatment of eosinophilic esophagitis in clinical practice |
| Q33832425 | Diagnosis of eosinophilic esophagitis: current approach and future directions |
| Q37098443 | Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis |
| Q38194007 | Diagnostics of eosinophilic esophagitis: clinical, endoscopic, and histologic pitfalls |
| Q37234472 | Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis |
| Q26860824 | Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies |
| Q36554740 | Effect of proton pump inhibitor on esophageal eosinophilia. |
| Q39276887 | Emerging therapeutic options for eosinophilic esophagitis |
| Q49382776 | Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis |
| Q89733022 | Eosinophilic Esophagitis in Adults: A Concise Overview of an Evolving Disease |
| Q39036890 | Eosinophilic Esophagitis: Current Aspects of a Recently Recognized Disease |
| Q37682047 | Eosinophilic Esophagitis: an Emerging Clinicopathologic Disease of Children and Adults |
| Q84124652 | Eosinophilic esophagitis |
| Q34997762 | Eosinophilic esophagitis and proton pump inhibitors: controversies and implications for clinical practice |
| Q36851150 | Eosinophilic esophagitis disease in children from West Virginia: a review of the last decade (1995-2004). |
| Q46486747 | Eosinophilic esophagitis in 29 pediatric patients |
| Q34996010 | Eosinophilic esophagitis in Saudi children: symptoms, histology and endoscopy results |
| Q30244585 | Eosinophilic esophagitis in an octogenarian: A case report and review of the literature |
| Q84009994 | Eosinophilic esophagitis without abundant eosinophils? The expanding spectrum of a disease that is difficult to define |
| Q90136076 | Eosinophilic esophagitis: Current concepts in diagnosis and treatment |
| Q38211918 | Eosinophilic esophagitis: a practical approach to diagnosis and management |
| Q37492712 | Eosinophilic esophagitis: concepts, controversies, and evidence |
| Q37997348 | Eosinophilic esophagitis: diagnostic tests and criteria |
| Q39195382 | Eosinophilic esophagitis: historical perspective on an evolving disease |
| Q37111841 | Eosinophilic esophagitis: management and pharmacotherapy |
| Q37492687 | Eosinophilic esophagitis: pathophysiology and optimal management |
| Q26741559 | Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental models |
| Q37464697 | Eosinophilic esophagitis: the newest esophageal inflammatory disease. |
| Q39251666 | Eosinophilic esophagitis: unclear roles of IgE and eosinophils |
| Q37856440 | Eosinophilic oesophagitis: latest intelligence |
| Q35753894 | Eosinophils in the oesophageal mucosa: clinical, pathological and epidemiological relevance in children: a cohort study |
| Q34518075 | Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota |
| Q38332391 | Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy |
| Q39295334 | Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation |
| Q37092267 | Esophageal eosinophilia in pediatric patients with cerebral palsy |
| Q37644238 | Esophageal intraepithelial eosinophils in dysphagic patients with gastroesophageal reflux disease |
| Q38153767 | Esophagitis in children: an update on current pharmacotherapy |
| Q83224573 | Fluoroscopic findings in pediatric eosinophilic esophagitis |
| Q45297999 | Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis |
| Q36942155 | Gastrointestinal eosinophilia |
| Q42524960 | High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults |
| Q37017109 | How to manage refractory GERD. |
| Q33972296 | Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. |
| Q47182041 | Lack of proton pump inhibitor trial prior to commencing therapy for eosinophilic esophagitis is common in the community |
| Q33695611 | Lack of seasonal variation in the incidence of eosinophilic oesophagitis in adolescent and adult non-PPI-responsive oesophageal eosinophilia midwestern US populations |
| Q44113590 | Localized esophageal eosinophilia: Is it an early manifestation of eosinophilic esophagitis or a subtype of gastroesophageal reflux disease? |
| Q53328595 | Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis. |
| Q52870720 | MAST CELLS DISTINGUISH EOSINOPHILIC ESOPHAGITIS IN PEDIATRIC PATIENTS. |
| Q37953961 | Management of pediatric eosinophilic esophagitis: an update |
| Q28080583 | Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches |
| Q33844314 | Management of refractory eosinophilic esophagitis |
| Q37736143 | Medical and nutrition management of eosinophilic esophagitis in children |
| Q52709104 | New Developments in the Diagnosis, Therapy, and Monitoring of Eosinophilic Esophagitis. |
| Q34490922 | Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells |
| Q36553408 | Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. |
| Q37103331 | Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature |
| Q37379008 | Pathology of eosinophilic esophagitis: what the clinician needs to know |
| Q37921854 | Pathology of oesophagitis |
| Q34561866 | Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications |
| Q40093651 | Presentation and Epidemiology of Gastroesophageal Reflux Disease |
| Q42483709 | Prevalence of esophageal eosinophils in patients with Barrett's esophagus |
| Q38012776 | Prevalence, clinical manifestations and endoscopic features of eosinophilic esophagitis: a pathological review in China |
| Q50186814 | Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: A Paradigm Shift |
| Q41820464 | Proton Pump Inhibitor-Responsive Esophageal Eosinophilia |
| Q43112574 | Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications |
| Q38240848 | Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity? |
| Q28082447 | Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences |
| Q36578734 | Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis |
| Q27008939 | Proton pump inhibitors for eosinophilic oesophagitis |
| Q46374558 | Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia |
| Q38105162 | Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis |
| Q54936077 | The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis. |
| Q41531483 | The changing faces of eosinophilic esophagitis: the impact of consensus guidelines at the University of South Florida |
| Q53650077 | The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia. |
| Q33649482 | The link between allergies and eosinophilic esophagitis: implications for management strategies |
| Q42622855 | The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor |
| Q39215912 | The pathology and causes of tissue eosinophilia in the gastrointestinal tract. |
| Q37222997 | The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy |
| Q36832496 | Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis |
| Q43969942 | Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis |
| Q52651158 | Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. |
| Q36826152 | Treatment of eosinophilic esophagitis: drugs, diet, or dilation? |
| Q35213444 | Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease |
| Q90229220 | Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference |
| Q36653890 | Upper gastrointestinal tract eosinophilic disorders: pathobiology and management |
| Q36872864 | Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review |
| Q80537569 | [Eosinophilic esophagitis : a cause of dysphagia] |
Search more.